Establishing the role of pre-implantation genetic diagnosis with human leucocyte antigen typing: what place do ''saviour siblings'' have in paediatric transplantation?

Archives of Disease in Childhood

Volumn 94, Issue 4, 2009, Pages 317-320

  Samuel, G N ^a   Strong, K A ^a,b   Kerridge, I ^a,b   Jordens, C F C ^a,b   Ankeny, R A ^a,b,d   Shaw, P J ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN;

EMBRYO TRANSFER; FERTILIZATION IN VITRO; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA TYPING; HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SAVIOR SIBLING; SIBLING; TISSUE TYPING; TRANSPLANTATION; UMBILICAL CORD BLOOD;

CHILD; DONOR SELECTION; ETHICS, MEDICAL; FEMALE; FERTILIZATION IN VITRO; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; PARENTS; PEDIATRICS; PREGNANCY; PREIMPLANTATION DIAGNOSIS; SIBLINGS;

EID: 64849109215     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2008.138529     Document Type: Review

References (31)

1. Lie J, Oudshoorn M, Schreuder GMT, et al. Histocompatibility typing procedures for selecting allogeneic haematopoietic stem cell donors. In: Atkinson K, ed. Clinical bone marrow and blood stem cell transplantation. Cambridge: Cambridge University Press, 2000:1066.
2. Alby N. The child conceived to give life. Bone Marrow Transplant 1992;9(Suppl. 1):95-6.
3. Verlinsky Y. Rechitsky S, Schoolcraft W, et al. Pre-implantation genetic diagnosis for Fanconi anaemia combined with HLA matching. JAMA 2001;285:3130-3.
4. Belkin L. The made-to-order savior: producing a perfect baby sibling. NYT Magazine 2001 July 1.
5. Pennings G, Schots R, Liebaers I. Ethical considerations on pre-implantation genetic diagnosis for HLA typing to match a future child as a donor of haematopoeietic stem cells to a sibling. Hum Reprod 2002;17:534-8.
6. Savulescu J. Substantial harm but substantial benefit. BMJ 1996;312:241-2.
7. Gratwohl A. Risk assessment in haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 2007;20:119-24.
8. Grewal SS, Kahn JP, MacMillan ML, et al. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood 2004;103:1147-51.
9. Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports: Centers for Disease Control and Prevention; Coordinating Center for Health Promotion; National Center for Chronic Disease Prevention and Health Promotion; 2004 December 2006.
10. National Marrow Donor Program. Likelihood of finding an unrelated donor or cord blood unit. http://www.marrow.org/PHYSICIAN/URD-Search-and-Tx/ Likelihood-of-Finding-an-URD-o/index.html (accessed September 2007).
11. Samuel G, Kerridge I, Vowels M, et al. Ethnicity, equity and public benefit: A critical evaluation of public umbilical cord blood banking in Australia. Bone Marrow Transplant 2007;40:729-34.
12. National Marrow Donor Program. National Marrow Donor Program-facts and figures. 2005. http://www.marrow.org/NEWS/MEDIA/Facts-and-Figures/facts- figures.pdf (accessed December 2007).
13. Pasquini MC, He V, Perez W. Current use and outcome of hematopoietic stem cell transplantation: part II - CIBMTR Summary Slides. CIBMTR Newsletter [serial online] 2006;12:5-10.
14. Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997;15:1767-77.
15. Balduzzi A, Valsecchi MG, Uderzo C, et al. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Lancet 2005;366:635-42.
16. Bleakley M, Shaw P, Nielsen J. Allogeneic bone marrow transplantation for childhood relapsed acute lymphoblastic leukemia: comparison of outcome in patients with and without a matched family donor. Bone Marrow Transplant 2002;30:1-7.
17. Dini G, Valsecchi MG, Micalizzi C, et al. Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission. Bone Marrow Transplant 2003;32:325- 31.
18. Bleakley M, Lau L, Shaw P, et al. Bone marrow transplantation for paediatric AML in first remission: a systematic review and meta-analysis. Bone Marrow Transplant 2002;29:843-52.
19. La Nasa G, Giardini C, Argiolu F, et al. Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood 2002;99:4350-6.
20. de Medeiros CR, Bitencourt MA, Zanis-Neto J, et al. Allogeneic hematopoietic stem cell transplantation from an alternative stem cell source in Fanconi anemia patients: analysis of 47 patients from a single institution. Braz J Med Biol Res 2006;39:1297- 1304.
21. Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001;97:1598-1603.
22. Saarinen-Pihkala UM, Gustafsson G, Ringdén O, et al. No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission. J Clin Oncol 2001;19:3406-14.
23. Gustafsson A, Remberger M, Winiarski J, et al. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting. Bone Marrow Transplant 2000;25:1059-65.
24. Al-Kasim FA, Thornley I, Rolland M, et al. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Br J Haematol 2002;116:483- 90.
25. Eapen M, Horowitz MM, Klein JP, et al. Higher mortality after allogeneic peripheralblood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clin Oncol 2004;22:4872-80.
26. Rocha V, Wagner JE Jr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000;342:1846-54.
27. Barker JN, Davies SM, DeFor T, et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigenmatched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001;97:2957-61.
28. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001;97:2962-71.
29. Hwang WY, Samuel M, Tan D, et al. A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrow Transplant 2007;13:444-53.
30. Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007;369:1947-54.
31. Pinto FO, Roberts I. Cord blood stem cell transplantation for haemoglobinopathies. Br J Haematol 2008;141:309-24.